Hemostasis biomarkers in multiple sclerosis.

Nicole ZiliottoF BernardiD JakimovskiM BaroniG MarchettiNiels P BergslandD P RamasamyB Weinstock-GuttmanF SchweserP ZamboniM RamanathanRobert Zivadinov

Published in: European journal of neurology (2018)

Decreased ADAMTS13, particularly in MS patients with cerebral microbleeds, which deserves further investigation, and increased PAI-1 and TFPI levels were observed in MS patients, which deserves further investigation. No relationship between hemostasis plasma levels and measures of disease severity was detected.

Keyphrases

multiple sclerosis
end stage renal disease
mass spectrometry
ms ms
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
subarachnoid hemorrhage
patient reported outcomes